---
title: "Vertex to buy Crinetics for USD 85 per share in USD 10 billion deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291838860.md"
description: "Vertex Pharmaceuticals agreed to acquire Crinetics for $85 per share in cash, valuing the equity at approximately $10 billion. The net purchase price is about $8.8 billion after accounting for acquired cash. Vertex plans to fund the deal with cash and debt, supported by $4.5 billion in bridge financing. The transaction is targeted to close in Q3 2026, pending regulatory approvals and shareholder consent, with expected accretion to non-GAAP operating income by 2029."
datetime: "2026-07-06T20:04:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291838860.md)
  - [en](https://longbridge.com/en/news/291838860.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291838860.md)
---

# Vertex to buy Crinetics for USD 85 per share in USD 10 billion deal

-   Vertex agreed to buy Crinetics for USD 85 per share in cash, valuing the equity at about USD 10 billion. \* Net purchase price is about USD 8.8 billion, reflecting estimated cash acquired. \* Closing is targeted for Q3 2026, subject to regulatory clearances and Crinetics shareholder approval. \* Vertex plans to fund the deal with cash and debt, backed by USD 4.5 billion in committed bridge financing. \* Vertex expects the acquisition to turn accretive to non-GAAP operating income in 2029. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vertex Pharmaceuticals Incorporated published the original content used to generate this news brief via Business Wire (Ref. ID: 20260706876183) on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CRNX.US](https://longbridge.com/en/quote/CRNX.US.md)
- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)

## Related News & Research

- [Vertex Pharmaceuticals just made a $10 billion acquisition worth watching](https://longbridge.com/en/news/293142937.md)
- [Vertex Pharmaceuticals (VRTX) Stock Trades Below Fair Value After Deal Plans](https://longbridge.com/en/news/293268909.md)
- [Brent crude could target $100/barrel if tensions continue](https://longbridge.com/en/news/293554186.md)
- [Brent oil's price briefly tops $100 per barrel, as stocks are set to drop on Wall Street](https://longbridge.com/en/news/293626798.md)
- [CRNX: Pipeline advances in acromegaly, CAH, and NETs, with strong financial runway into 2030](https://longbridge.com/en/news/293389069.md)